Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”
May 12, 2022 05:41 PM
Services Provider Haixin Zhihui Raises CNY Hundreds of Mns in Series B Funding
Founded in January 2018, Haixin Zhihui is an artificial intelligence company focusing on the oncology field, it specializes in intelligent tumor diagnosis and treatment and has developed the first oncology intelligent diagnosis and treatment system in China.
Yesterday 04:04 PM
Junshi Announces Its Anti-Covid Phase III Drug Reaches Primary Endpoint
Founded in August 2021, Juntuo Biotech is dedicated to the R&D processes in biomedicine and vaccines. The company's innovative R&D pipelines cover viral vaccines, bacterial vaccines, genetically engineered vaccines, conjugate vaccines, and multivalent vaccines.
May 24, 2022 03:45 PM